Cargando…

Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care

SIMPLE SUMMARY: Adrenocortical cancer (ACC) is a rare malignancy, often diagnosed late and with a poor prognosis. Currently, ACC best management is achieved in referral centers, where a multidisciplinary approach (endocrinologists, oncologists, surgeons, radiologists and radiotherapists) can interce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruggiero, Elena, Tizianel, Irene, Caccese, Mario, Lombardi, Giuseppe, Pambuku, Ardi, Zagonel, Vittorina, Scaroni, Carla, Formaglio, Fabio, Ceccato, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739560/ https://www.ncbi.nlm.nih.gov/pubmed/36497381 http://dx.doi.org/10.3390/cancers14235901

Ejemplares similares

Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
por: Ruggiero, Elena, et al.
Publicado: (2023)

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
por: Tizianel, Irene, et al.
Publicado: (2022)

An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Imaging or Adrenal Vein Sampling Approach in Primary Aldosteronism? A Patient-Based Approach
por: Tizianel, Irene, et al.
Publicado: (2022)

Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients
por: Lombardi, Giuseppe, et al.
Publicado: (2019)

Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
por: Birzu, Cristina, et al.
Publicado: (2020)

The role of radiation therapy and systemic treatments in meningioma: The present and the future
por: Caccese, Mario, et al.
Publicado: (2023)

Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study
por: Ceccato, Filippo, et al.
Publicado: (2021)

CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study
por: Crimì, Filippo, et al.
Publicado: (2023)

Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review
por: Crimì, Filippo, et al.
Publicado: (2022)

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
por: Olioso, Debora, et al.
Publicado: (2021)

Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022)

Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy
por: Brunello, Antonella, et al.
Publicado: (2022)

Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients
por: Galiano, Antonella, et al.
Publicado: (2022)

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
por: Lombardi, Giuseppe, et al.
Publicado: (2021)

Therapeutic Plasma Exchange for the Treatment of Hyperthyroidism: Approach to the Patient with Thyrotoxicosis or Antithyroid-Drugs Induced Agranulocytosis
por: Tizianel, Irene, et al.
Publicado: (2023)

Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
por: Puglisi, Soraya, et al.
Publicado: (2020)

An incidental finding behind adrenal incidentaloma
por: Crimì, Filippo, et al.
Publicado: (2022)

Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016)

Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
por: Padovan, Marta, et al.
Publicado: (2021)

Clinical use of pasireotide for Cushing’s disease in adults
por: Ceccato, Filippo, et al.
Publicado: (2015)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome
por: Barbot, Mattia, et al.
Publicado: (2020)

How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)
por: Scaroni, Carla, et al.
Publicado: (2022)

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study
por: Caccese, Mario, et al.
Publicado: (2020)

Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency
por: Ceccato, F., et al.
Publicado: (2022)

Treatment of Malignant Gliomas in Elderly Patients: A Concise Overview of the Literature
por: Farina, Patrizia, et al.
Publicado: (2014)

Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2019)

Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent Hypercortisolism
por: Pinelli, Silvia, et al.
Publicado: (2021)

Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
por: Sabbadin, Chiara, et al.
Publicado: (2021)

Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma
por: Torresan, F, et al.
Publicado: (2021)

PET/MR in recurrent glioblastoma patients treated with regorafenib: [(18)F]FET and DWI-ADC for response assessment and survival prediction
por: Lombardi, Giuseppe, et al.
Publicado: (2022)

Caring for Patients with Advanced Stage Cancer at the Time of COVID‐19
por: Brunello, Antonella, et al.
Publicado: (2020)

Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art
por: Bergo, E., et al.
Publicado: (2016)

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
por: Ceccato, Filippo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72sckvmv0f6qt7nhvooapem4v1